( 10) : 1439-1448.[10]FALAGAS M E,VOULOUMANOU E K,SAMONIS G,et al.Fosfomycin [J]. Clin Microbiol Rev,2016,29( 2) : 321-347.[11]JIANG Y,SHEN P,WEI Z,et al. Dissemination of a clonecarrying a fosA3-harbouring plasmid mediates high fosfomycinresistance tate of KPC-producing Klebsiella pneumonia in China[J]. Int Antimicrob Agents,2015,45( 1) : 66-70.[12]DIEZ A M,MOROSINI M,TEDIM A P,et al. Antimicrobialactivity of fosfomycin-tobramycin combination against Pseudomonasaeruginosa isolates assessed by timekill assays and mutantprevention concentrations [J]. Antimicrob Agents Chemother,2015,59( 10) : 6039-6045.[13]PETER G,CAROL A,DAVID ANDES,et al. Clinical practiceguidelines for the management of candidiasis: 2009 update by theInfectious Diseases Society of America [J]. Clin Infect Dis,2009,48( 5) : 503-535.[14]杨莉莉,邓瑛,刘敏,等. 血浆( 1-3) -β-D 葡聚糖对侵袭性真菌感染诊断的临床意义[J]. 检验医学与临床,2016,13( 10) : 1364-1366.[15]WILLIAMSON D R,ALBERT M,HEELS-ANSDELL D,et al.Thrombocytopenia in critically ill patients receiving thrombopro-phylaxis: Frequency,risk factors,and outcomes [J]. Chest,2013,144( 4) : 1207-1215.[16]吴骎,任建安. 外科感染合并血小板减少诊治进展[J]. 中国实用外科杂志,2016,36 ( 2) : 241-244.[17]STANWORTH S J,WALSH T S,PRESCOTT R J,et al.Thrombocytopenia and platelet transfusion in UK critical care: Amulticenter observational study [J]. Transfusion,2013,53( 5) :1050-1058.[18]SINGH A, GOYAL M, SHARMA D. Thrombocytopenia inmalaria: Its usefulness in a clinical setting. A study from WesternRajasthan,India [J]. Trop Doct,2014,44( 4) : 205-208.[19]DELLINGER R P,LEVY M M,RHODES A,et al. Survivingsepsis campaign:International guidelines for management ofsevere s...